Dana-Farber Cancer Institute
Boston, Massachusetts, United StatesPurpose
to develop a new vaccine platform for HIV based on the hypothesis that immunodominant regions of the virus may be irrelevant to neutralizing the virus and also prevent access to neutralizing epitopes in conserved regions
Grantee
Division
Global Health
Date
MAY 2009
Region served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
18
Grantee location
Boston, Massachusetts, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.